Adelphi Values
  • About
  • PCO
    • Literature and COA instrument reviews
    • Qualitative patient-centered research and evaluation of COAs
    • COA instrument development or modification
    • Patient Preference Research
    • Psychometric evaluation and statistical analysis of COAs
    • COA regulatory submissions and support
    • Scientific dissemination and training
  • PROVE
    • Value Insight & Communication
    • Health Economic & Data Analysis
    • Payer, Pricing & Reimbursement
  • Therapeutic Expertise
  • Our Publications
  • Team
  • Careers
  • Contact
Select Page

Planning the PICO and designing the literature reviews for the JCA Evidence synthesis

by Rachel Ryder | Jul 23, 2024

Planning the PICO and designing the literature reviews for the JCA Evidence synthesis Applying the lessons learned from EUnetHTA21 The challenge Our client has an asset anticipated to qualify for JCA. They could not benefit from JSC. Given the short timelines between...

Development of a summary framework for communication of payer needs

by adelphivalues1 | Oct 31, 2023

Development of a summary framework for communication of payer needs A conceptual summary framework of payer requirements to guide development of pharmaceuticals from the payer perspective The challenge The silo mentality within pharmaceutical companies was recognised...

Rapid economic analysis to support an internal business decision

by adelphivalues1 | Oct 31, 2023

Rapid economic analysis to support an internal business decision Cost effectiveness and budget impact modelling to assess a new investment opportunity from a health economic and payer perspective The challenge Our client had the opportunity to invest in a new product:...

Delphi panel to elicit expert consensus relating to the assessment of European Immunization programmes in paediatrics

by adelphivalues1 | Oct 30, 2023

Delphi panel to elicit expert consensus relating to the assessment of European Immunization programmes in paediatrics Insights obtained from scientific experts within paediatric infectious disease to validate the scoring system of a tool developed to assess national...

Virtual advisory boards to gain HTA insights for a novel therapy in follicular lymphoma

by adelphivalues1 | Oct 30, 2023

Virtual advisory boards to gain HTA insights for a novel therapy in follicular lymphoma Facilitation of four virtual advisory boards with key stakeholders to gain insights for market access strategy in a new indication The challenge Our client was preparing to seek...
« Older Entries

Privacy Policy  | Cookie Notice | Privacy Shield | Recruitment Privacy Notice | California Consumer Privacy Statement | Terms & Conditions

Do not reproduce without permission An Omnicom Group Inc Com

Company Reg No: 2761308 Registered Office: Bankside 3 90-100 Southwark St, London SE1 0SW

© 2023 Adelphi Values | Designed by Embrace Marketing Ltd

© 2025 Adelphi Values | Designed by Embrace Marketing Ltd

Privacy Policy  | Cookie Notice | Data Privacy Framework Policy | Recruitment Privacy Notice | California Consumer Privacy Statement | Terms & Conditions

Do not reproduce without permission. An Omnicom Group Inc Company

Company Reg No: 2761308

Registered Office: Bankside 3 90-100 Southwark St, London SE1 0SW

×

Planning the PICO and designing the literature reviews for the JCA Evidence synthesis

Applying the lessons learned from EUnetHTA21

The challenge

Our client has an asset anticipated to qualify for JCA. They could not benefit from JSC. Given the short timelines between communication of the PICOs by the JCA working group and the submission (100 days), the PICO sets need to be anticipated to plan the evidence generation.

The solution

We simulated the JCA process through landscape analysis, our client internal resources and our stakeholders’ network. We used our previous experience in PICO planning projects to select the most likely and second most likely PICO sets. Stakeholder consultation was used to optimise and justify the choices. We structured the literature reviews to accommodate selection of PICO sets and updates.

Key results

We derived a manageable number of PICO sets reflecting the reimbursement landscape in the therapeutic area across Europe and addressing the likely policy questions of the member states. The sets have been externally validated. The evidence synthesis is structured in such a way to be updating easily and accommodate requirements from authorities.

Value to the client

Our client is well prepared for the upcoming JCA of their asset. The PICO sets have strong expert justification and evidence generation is structured in a flexible way to accommodate JCA requirements.

Manage Cookie Consent
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always active
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Analytics
The technical storage or access that is used exclusively for statistical purposes. We’d like to set analytic software cookies i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}